Citation Impact
Citing Papers
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
2009
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
2004
Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein
2000 StandoutNobel
Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent
1998
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Pancreatic cancer
2004 Standout
Stepping out of the flow: capillary extravasation in cancer metastasis
2007
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
2005
Microenvironment of the murine mammary carcinoma 4T1: Endogenous IFN-γ affects tumor phenotype, growth, and metastasis
2008
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Unprecedented laser action from energy transfer in multichromophoric BODIPY cassettes
2011
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
C-reactive Protein
2004 Standout
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma
2002
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein
1993
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity
2012 StandoutNobel
Immunological self/nonself discrimination
1999
Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells
1999
Loss of T-cell receptor-CD3ζ and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma
2001
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
2016 StandoutNobel
Use of tumour-responsive T cells as cancer treatment
2009
Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
1999 StandoutNobel
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
Properties of four acute phase proteins: C-reactive protein, serum amyloid a protein, α1-acid glycoprotein, and fibrinogen
1990
Hematopoietic Stem-Cell Transplantation
2006 Standout
Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes.
1995
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Sarcoidosis
1997 Standout
Microenvironmental regulation of metastasis
2008 Standout
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Adoptive-cell-transfer therapy for the treatment of patients with cancer
2003
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Exosomes: composition, biogenesis and function
2002 Standout
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Pancreatic cancer
2011 Standout
A novel role of metalloproteinase in cancer-mediated immunosuppression.
2001
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
2008
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
2004 StandoutNobel
IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques
2003 StandoutNobel
Attenuation of CD8+ T-Cell Function by CD4+CD25+ Regulatory T Cells in B-Cell Non-Hodgkin's Lymphoma
2006
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
1998 StandoutScience
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen
2005
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Structural modification strategies for the rational design of red/NIR region BODIPYs
2014 Standout
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
2014 Standout
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
2002
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
1999 StandoutScienceNobel
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor
2003
A second major native von Hippel–Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor
1998
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium Disease
1993 Science
Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing
2000
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity
2002 StandoutNobel
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
1993
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of Mark Edinger being referenced
Defective Granzyme B Gene Expression and Lytic Response in T Lymphocytes Infiltrating Human Renal Cell Carcinoma
1997
L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants
1991
Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity
1990
Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-hodgkin's lymphomas
1995
3-Carboxy-6-chloro-7-hydroxycoumarin: A highly fluorescent, water-soluble violet-excitable dye for cell analysis
2008
Interleukin 7 enhances the proliferation and effector function of tumor‐infiltrating lymphocytes from renal‐cell carcinoma
1993
Characterization of Tumor-Infiltrating Lymphocyte Subsets from Human Renal Cell Carcinoma: Specific Reactivity Defined by Cytotoxicity, Interferon-?? Secretion, and Proliferation
1994
Characterization of a Human Renal Cell Carcinoma Specific Cytotoxic CD8+ T Cell Line
1992
Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
1997
Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs.
1984
Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein.
1982
Experimental Beryllium-Induced Lung Disease
1984
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
1994
The Influence of Cytokines on the Adhesion of Renal Cancer Cells to Endothelium
1996
Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma.
1989
Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
1990
A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment.
1998